Pharma & Biopharma

Driving innovations in the pharma & biopharma market

The pharmaceutical and biopharmaceutical markets are evolving faster than ever - driven by breakthroughs in personalized medicine, nucleic acid therapies, and digitalization. Global biopharma is projected to nearly double by 2032, and the pharmaceutical market is expected to exceed $3 trillion by 2034. But growth comes with complexity: tighter regulations, sustainability demands, supply chain vulnerabilities, and shifting investment patterns are reshaping the industry.

At Evonik, we don’t just keep pace with these changes - we help you turn them into opportunities. As a trusted partner to leading life science companies for decades, we bring deep market insight and a commitment to resilience. Our focus is on enabling you to deliver life-saving therapies reliably, affordably, and sustainably.

News

August 27, 2026

Health Care

Evonik expands lipid-based drug delivery capabilities with new GMP manufacturing facility in Vancouver

Evonik is investing in a new GMP drug product manufacturing facility for lipid-based drug delivery in Vancouver, Canada. The facility will increase Evonik’s development and manufacturing capacity, helping pharmaceutical and biotech customers bring lipid-based pharmaceutical products including vaccines, therapeutics, and other advanced medicines from development through commercial scale.

August 18, 2026

Health Care

Evonik provides customers with Life Cycle Assessment data for selected EUDRAGIT® polymers

Evonik now offers its customers cradle-to-gate LCA data for selected EUDRAGIT® functional polymers. These results are derived from Evonik’s TÜV-certified LCA method. This data supports customers’ Scope 3 emissions (indirect emissions) reporting and underscores Evonik’s commitment to greater transparency across the value chain.

July 15, 2026

Health Care

Evonik appoints Brenntag as the exclusive European distributor for REXIM® GMP-grade amino acids

Evonik REXIM has entered into an agreement with Brenntag Specialties Pharma for the exclusive distribution of its REXIM® GMP-grade amino acids across most of Europe. Under the agreement, Brenntag will assume responsibility for market development and distribution in key regions including the DACH region, the UK, France, Benelux, Scandinavia, Central and Eastern Europe, Israel and Turkey.

July 14, 2026

Health Care

Evonik partners with evitria to accelerate early biologics development

Evonik has partnered with global antibody expression specialist evitria to offer a ready-to-use transient protein expression kit based on CHO cells for biopharmaceutical research and development. Designed to enable faster, more reliable, and scalable protein production, the kit addresses key challenges in transient protein expression workflows.

July 08, 2026

Health Care

Evonik invests US$100 million to upgrade its U.S. drug substance contract manufacturing site

Evonik is making a significant investment to strengthen manufacturing capabilities at its Lafayette (Tippecanoe), Indiana facility. Over the next five years, the company will invest US$100 million to modernize key equipment – including 100 m³ reactors and other critical systems – enhancing reliability, enabling greater automation, and improving ergonomics and efficiency.

June 19, 2026

Health Care

Evonik sells Hanau-based production assets for pharmaceutical ingredients to ProChem

Evonik is selling selected production assets for pharmaceutical ingredients in Hanau, Germany to the contract manufacturer ProChem Group. The transaction, which is expected to close on June 19, 2026, supports the growth strategy of Evonik’s Health Care business.

Our focus areas

Drug delivery

Drug substance

Biopharma

Hospital hygiene

Leading beyond chemistry to improve life

The Health Care business at Evonik is a global innovation hub for the world’s leading life science companies. We support customers across the entire product lifecycle - from early development to commercial manufacturing - with a broad portfolio of advanced drug delivery technologies, CDMO services for APIs and HPAPIs, and high-performance biopharma solutions. Backed by scientific excellence, sustainability, and a trusted network of western-based facilities, we help the world’s leading life science companies accelerate innovation and improve patient outcomes - today and tomorrow.

Drug delivery - the application areas we serve:

^{ORAL DRUG DELIVERY - FUNCTIONAL POLYMERS}

^{ORAL DRUG DELIVERY - FORMULATION & DEVELOPMENT SERVICES}

^{PARENTERAL DRUG DELIVERY - FUNCTIONAL POLYMERS}

^{PARENTERAL DRUG DELIVERY - LIPIDS}

^{PARENTERAL DRUG DELIVERY CDMO - FUNCTIONAL POLYMERS}

^{PARENTERAL DRUG DELIVERY CDMO - LIPIDS}

^{PHARMACEUTICAL EXCIPIENTS}

Drug substance - the application areas we serve:

^{ACTIVE PHARMACEUTICAL INGREDIENTS (APIS)}

^{CDMO FOR APIS & INTERMEDIATES}

^{CDMO FOR HPAPIS (HIGH POTENCY APIS)}

^{CATALYSTS FOR PHARMACEUTICAL SYNTHESIS}

Biopharma - the application areas we serve:

^{BIOPHARMA & BIOPROCESSING}

^{PRECISION FERMENTATION CDMO}

^{PHARMACEUTICAL & NUTRACEUTICAL AMINO ACIDS}

Hospital hygiene - the application areas we serve:

^{HOSPITAL HYGIENE}

^{DECONTAMINATION}

Upcoming events

CPHI Korea

We will be showcasing our latest solutions for the pharmaceutical industry at this year's CPHI Korea. Meet our experts at the show and learn more about how our differentiating products and solutions for drug substance, drug delivery and biopharma can bring your drug product to the next level.

On-site - In-person

South Korea

08/25/2026 - 08/27/2026

From knowledge to confidence: Customized release profiles with EUDRAGIT® polymers

This one-day seminar is designed to empower professionals in formulation development, process optimization, scale-up, and production. By combining expert insights, case studies, and practical demonstrations, the forum will help participants transform their understanding of EUDRAGIT® polymers into actionable confidence for daily work.

On-site - In-person

Indonesia

09/01/2026

EUDRAGIT® Advanced Workshop: Formulation Strategies and Manufacturing Approaches for Challenging Drugs

This workshop will be an excellent opportunity for technical staff in the pharmaceutical industry to learn about the use of EUDRAGIT® polymers in modified release formulations, oral delivery of peptide drugs, spray drying techniques, and hot melt extrusion approaches for advanced drug delivery.

On-site - In-person

United States of America

09/03/2026

APS PharmSci

We will be showcasing our latest solutions for the pharmaceutical industry at this year's APS PharmSci. Meet our experts at the event and learn more about how our differentiating products and solutions for drug delivery can bring your project to the next level.

On-site - In-person

United Kingdom

09/07/2026 - 09/09/2026

4th RNA Vaccines & Therapeutics Conference

We will be showcasing our latest solutions for mRNA & gene delivery at 4th RNA Vaccines & Therapeutics Conference. Meet our experts at the conference and learn more about how our differentiating products and solutions can bring your project to the next level.

On-site - In-person

United Kingdom

09/15/2026 - 09/16/2026

ChemOutsourcing

We will be showcasing our latest solutions for the pharmaceutical industry at this year's ChemOutsourcing. Meet our experts at the show and learn more about how we can provide you with the confidence and expertise you need to tackle complex drug development and manufacturing challenges. Learn about our leading position as a drug substance CDMO and our proven track record built on quality, supply security and a strong commitment to sustainability.

On-site - In-person

United States of America

09/15/2026 - 09/17/2026

Global innovation hub for the world’s leading life science companies

Our strategy is built around science-based innovation, customer-centric business models, and operational agility. In partnership with the pharma and biopharma industry, we’re driving innovation across key areas such as drug delivery technologies, bioresorbable excipients, pharmaceutical lipids, and advanced solutions for biopharmaceutical manufacturing. Central to this progress is our focus on precision biosolutions, which serve as a major growth driver and a cornerstone of our strategy.

Our portfolio of products and services for the pharma and biopharma market

With trusted brands like EUDRAGIT® for controlled-release systems and EUDRACAP® advanced functional capsules, plus comprehensive formulation development and manufacturing services, we help you overcome challenges in oral drug delivery.

Furthermore, we work with you on cutting-edge parenteral drug delivery solutions. From high-purity lipids, liposomes, and LNPs for complex biologics to bioresorbable polymers like RESOMER® and LACTEL® for controlled-release injectables, we provide the expertise and capabilities to accelerate your development.

Product/service	Class of material/service	Properties	Application area
AEROPERL®	Fumed silica powder	Glidant	Oral drug delivery
AEROSIL®	Fumed silica powder	Glidant	Oral drug delivery
Chematic®	Cleaning agents	Tailored for EUDRAGIT® polymers	Oral drug delivery
DuoCoat®	Advanced oral drug delivery technology	Drug release in colon or upper small intestine	Oral drug delivery
EUDRACAP®	Functional ready-to-fill pre-coated capsules	Modified release	Oral drug delivery
EUDRAGIT®	Functional polymer	Modified release	Oral drug delivery
EUDRATEC®	Advanced oral drug delivery technologies	Special release profiles	Oral drug delivery
Phloral®	Advanced oral drug delivery technology	Drug release in colon or upper small intestine	Oral drug delivery
LACTEL®	Bioresorbable polymer	Modified degradation time	Parenteral drug delivery
RESOMER®	Bioresorbable polymer	Modified degradation time	Parenteral drug delivery
Lipex®	Liposome extruders	Seamless scalable	Parenteral drug delivery
Northern Lipids	Lipids	High quality	Parenteral drug delivery
PhytoChol® Inject	Non-animal-derived cholesterol	High-purity	Parenteral drug delivery
PhytoSquene®	Non-animal-derived squalene	Consistent quality	Parenteral drug delivery
Complex parenterals	CDMO services	Western-based production network	Parenteral drug delivery
Lipid nanoparticles (LNP)	CDMO services	Western-based production network	Parenteral drug delivery
Lipids	CDMO services	Western-based production network	Parenteral drug delivery

Evonik delivers end-to-end CDMO services for the development and manufacturing of drug substances. We specialize in custom synthesis of complex APIs and intermediates, including highly potent APIs (HPAPIs), as well as generic APIs and intermediates. Our portfolio of differentiating technologies and western-based manufacturing facilities, enable sustainable and innovative production of advanced molecules—giving you flexibility and speed from early development through commercial scale.

Product/service	Class of material/service	Property	Application area
Complex APIs	CDMO services	Western-based production network	Pharma & Biopharma
High potency APIs	CDMO services	Western-based production network	Pharma & Biopharma
Controlled substances	CDMO services	Western-based production network	Pharma & Biopharma
mPEG and PEG linkers	CDMO services	Western-based production network	Pharma & Biopharma
Catalysts for pharma synthesis	Catalysts	High quality	Pharma & Biopharma

Evonik supports the biopharmaceutical industry with high-performance cell culture solutions designed to optimize productivity and quality. Our portfolio includes cQrex® peptides, amino acids, PhytoChol® cholesterol, and essential carbohydrates, along with advanced purification products like MaxiPure® Polysorbate 80. Combined with our expertise and services, we help you streamline upstream processes, enhance consistency, and accelerate the development of life-saving biologics—so you can bring therapies to patients faster.

Product/service	Class of material/service	Property	Application area
Amino acids	Amino acids	High-purity	Biopharma & Bioprocessing
cQrex®	Peptides	Stable & soluble	Biopharma & Bioprocessing
CreaCyte® rHSA	Recombinant human albumin	Highly pure and animal-origin-free	Biopharma & Bioprocessing
eviCHO	Expression kit for protein expression	Ready-to-use	Biopharma & Bioprocessing
MaxiPure®	Polysorbate 80	Ultra-high purity	Biopharma & Bioprocessing
PhytoChol® Biopharma	Non-animal-derived cholesterol	High-purity	Biopharma & Bioprocessing
Specialty carbohydrates	Non-animal-derived specialty carbohydrates	High-purity	Biopharma & Bioprocessing
Precision fermentation	CDMO service	Western-based production network	Biopharma & Bioprocessing

The use of sterilants is strongly regulated across the globe.

Evonik’s peracetic acid can be used for infection control in medical environments. Our formulations support our customers in meeting high standards for medical devices, ensuring high safety and efficacy.

Product/service	Class of material/service	Properties	Application areas
PERACLEAN®	Peracetic acid	Disinfectant and sterilant	Hospital hygiene
PERSYNT®	Hydrogen peroxide	Disinfectant in wound and dental care Excipient	Hospital hygiene

Product stories

Interview: How recombinant albumin can help de-risk cell therapy manufacturing

Evonik and InVitria are helping biopharma manufacturers de-risk cell therapy production with recombinant human serum albumin designed for consistency, purity, and supply security. Learn more in our interview with Jake Hanks and Dr. Sabrina Metze.

People getting a vaccination to prevent pandemic concept. Mature Woman in medical face mask receiving a dose of immunization coronavirus vaccine from a nurse at the medical center hospital

Vaccination

Better Pandemic Preparedness

How Evonik, Ethris, and EU partners are developing a next‑generation nasal mRNA influenza vaccine to strengthen pandemic readiness and improve global protection.

Building a smarter, stronger, more resilient supply chain

Global supply chains are under constant pressure. Learn how Evonik is strengthening reliability, resilience, and transparency in Drug Substance manufacturing – and why leadership and digitalization are key to staying ahead.

For the sensitive

Until now, many modern therapeutics could only be administered by injection, which is less convenient than taking them orally. Eudracap colon is the first capsule that changes this, releasing sensitive contents specifically in the colon, where they are most effective.

Choosing the right L-Glutamine peptide to improve your cell culture performance

L-Glutamine is used by practically all human and animal cells as a carbon source for growth and as a building block for proteins. Due to its important role in energy supply, it is typically present in cell culture media at higher concentrations than other amino acids.

The Rise of Biosimilars: Opportunities and Challenges

Biosimilars serve as cost-effective alternatives to innovative biological drugs, ensuring patient access to affordable medications. In this post, Spandan Mishra explains how Evonik’s cQrex® portfolio can help save costs in biosimilar development and manufacturing.

ANY QUESTIONS? JUST CONTACT US.

Our global team of experts is ready to support you with all questions around our product and service portfolio for pharma and biopharma. Contact us to profit from more than 70 years of application know-how and our unparalleled track record.

Send us a message